diabetes. I am posting this article for both Adam and Jacob
because unrelated researchers in two different locations made
this discovery at the same time.
At this time I am trying to get Adam to get the final class
project on Attention Deficit Disorder (ADHD)
for a Bioinformatics Class he took last fall that showed
some connection to genetics through G-WAS on a Manhattan
Plot ready for publication.
This connection needs to get out there so researchers
can do MORE studies.
The drug metformin is used to fight diabetes -- but
it could be used to fight something far more deadly.
A
new study has found that Metformin, a drug commonly used in the treatment of
diabetes, may reduce the risk of dying from some cancers — a huge breakthrough
that could provide the medical community with a new tool to battle cancer.
Scientists
made the discovery while examining postmenopausal women who have type 2
diabetes, according to a HealthDay News report.
The findings were based on
data from 145,826 postmenopausal women who were between the ages of 50 and 79,
and the data comes from between 1993 and 1998 for a Women’s Health Initiative
study, according to the report.
Postmenopausal
women with diabetes were about 25 to 35 percent more likely to develop certain
types of cancers like colon and endometrial cancers, as well as non-Hodgkin’s
lymphoma, and the risk was double for liver and pancreatic cancers.
However,
the study had extremely hopeful news: women with cancer who took metformin for
type 2 diabetes saw a reduced risk overall of dying from cancer.
Researchers at
Massachusetts General Hospital noticed this link as well.
Metformin Chemical Formula
No comments:
Post a Comment